The prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly populations in China
- PMID: 30325950
- PMCID: PMC6191112
- DOI: 10.1371/journal.pone.0205709
The prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly populations in China
Abstract
Objectives: This study aimed to examine the prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly Chinese populations.
Methods: The 2010-2012 China National Nutrition and Health Survey (CNNHS) is a nationally representative cross-sectional study. In the present study, a total of 69,974 participants aged ≥ 45 years were included. Dyslipidemia was defined based on the Chinese adult dyslipidemia prevention guide. A multivariable logistic regression model was performed to examine the associations between risk factors and dyslipidemia.
Results: The prevalence of dyslipidemia was 39.9%, 46.8%, and 59.3% in participants with normal glucose, prediabetes, and type 2 diabetes mellitus (T2DM). Women had a lower dyslipidemia prevalence than men (38.7% vs. 43.3%). Dyslipidemia prevalence was positively associated with the education level and inversely correlated with the physical activity level, and negatively related to age only among prediabetes and T2DM groups (P for trend < 0.05). Obesity, abdominal obesity, and hypertension were associated with dyslipidemia.
Conclusions: The prevalence of dyslipidemia was relatively high among middle-aged and elderly T2DM person. There are different associations between multiple risk factors and dyslipidemia in different diabetic progression stages.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Haffner SM. Dyslipidemia management in adults with diabetes. Diabetes Care. 2004; 27 Suppl 1: S68–71. - PubMed
-
- Hirakawa Y, Ninomiya T, Kiyohara Y, Murakami Y, Saitoh S, Nakagawa H, et al. Age-specific impact of diabetes mellitus on the risk of cardiovascular mortality: An overview from the evidence for Cardiovascular Prevention from Observational Cohorts in the Japan Research Group (EPOCH-JAPAN). J Epidemiol. 2017; 27: 123–129. 10.1016/j.je.2016.04.001 - DOI - PMC - PubMed
-
- Mooradian AD. Cardiovascular disease in type 2 diabetes mellitus: current management guidelines. Arch Intern Med. 2003; 163: 33–40. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical